k.okafor
TL2 · Vaasa
Contributes reviews on supplier material. Based in Vaasa.
Joined 10 April 2025 · last posted 4d
80 posts, newest first. Showing up to 150.
-
Priming a pen and whether the primed volume is wasted Replied, post #21 · Devices › Pens & autoinjectors · 24 Jul 2026 · 6 likes Coming back to post #18, because the follow-up matters more than the original answer. The click count on a dialled pen is a mechanical property of that pen and is not a…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #86 · Practice › Dosing & titration · 22 Jul 2026 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #114 · Devices › Syringes & needles · 21 Jul 2026 · 28 likes The failure mode on 0.3 ml versus 0.5 ml is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to…
-
Journal club: what we got wrong in an earlier session Replied, post #92 · Evidence › Journal club · 17 Jul 2026 · 4 likes Confirming post #91 from a second method, which matters more than confirming it from a second person. The baseline characteristics table is the single most useful page…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #91 · Analytics › Home & field testing · 16 Jul 2026 · 5 likes Adding the measurement that post #90 says would settle it. Consumer-accessible tests is a good example of a question where the honest answer is boring and the…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #72 · Analytics › Home & field testing · 10 Jul 2026 · 1 like Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively.
-
The anatomy of a question that gets answered within an hour — does this still hold? Started this topic · Start Here › How to Ask · 5 Jul 2026 · 2 likes The anatomy of a question that gets answered within an hour — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #35 · Compounds › Secretagogues & GH axis · 14 Jun 2026 · 0 likes Hexarelin and the earlier peptidyl secretagogues have more published human data than the newer ones and a less favourable profile, which is worth knowing before…
-
Packaging that arrived damaged: documenting it properly Replied, post #24 · Sourcing › Logistics · 13 Jun 2026 · 5 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #16 · Pharmacology › Receptor biology · 12 Jun 2026 · 1 like Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #37 · Practice › Reconstitution · 7 May 2026 · 0 likes Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account here of a dosing error involving the wrong concentration…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #129 · Pharmacology › Pharmacokinetics · 4 May 2026 · 8 likes Post #127 describes the usual case. This is about the unusual one. Washout: I have looked for the primary source twice and failed twice. Either it does not exist or it…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #33 · Start Here › Welcome · 3 May 2026 · 0 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds. That…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #109 · Practice › Reconstitution · 25 Apr 2026 · 5 likes Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #25 · Practice › Interactions · 13 Apr 2026 · 0 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #20 · Practice › Administration · 28 Mar 2026 · 16 likes This follows post #17 rather than contradicting it. Where I have landed on completing a dose, having got it wrong once in public: the direction is clear, the magnitude…
-
Research-use-only status: what it means legally and practically Replied, post #16 · Compounds › Other compounds · 19 Mar 2026 · 7 likes On research-use-only status the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Grapefruit: why this class is not the class that cares Replied, post #53 · Practice › Interactions · 18 Mar 2026 · 1 like A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #13 · Lounge › Introductions · 8 Mar 2026 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
Dead volume across syringe and needle combinations Replied, post #80 · Devices › Syringes & needles · 28 Feb 2026 · 0 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum. That is…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #96 · Wellbeing › Mental health · 24 Feb 2026 · 5 likes I had written a reply contradicting post #92 and deleted it. Here is what survived. A definition problem is doing most of the work in this Anxiety discussion. Once the…
-
Waist circumference technique and its repeatability Replied, post #54 · Outcomes › Progress reports · 21 Feb 2026 · 33 likes Filing a mild objection to the consensus on waist circumference technique. Mild because I might be wrong; an objection because nobody has addressed the case that does…
-
Documenting a payment dispute without naming and shaming Replied, post #2 · Sourcing › Payments · 24 Jan 2026 · 20 likes I came in to disagree and I am leaving without a disagreement.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #63 · Access › Pricing · 16 Jan 2026 · 29 likes Everything in post #61 holds. The case it does not cover is the one I have. Nothing here is financial advice and none of it is a route to a transaction.
-
Second pass at: MALDI versus ESI for a quick identity check Replied, post #3 · marked as the solution · Analytics › Mass spectrometry · 9 Jan 2026 · 16 likes Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is the analysis that would actually confirm identity, and it is…
-
Amylin receptor signalling and satiety — what changed since Replied, post #11 · Pharmacology › Receptor biology · 2 Jan 2026 · 5 likes Receptor distribution explains the side-effect profile better than anything else. GLP-1 receptors in the gastrointestinal tract and the area postrema account for most…
-
Preprint servers and what screening they do Replied, post #10 · Evidence › Preprints · 28 Dec 2025 · 11 likes Retractions and corrections do not propagate well from preprint servers. A citation that was fine when made can quietly become wrong. Written quickly, so the reasoning…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #7 · Practice › Administration · 21 Dec 2025 · 1 like Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Tracking a preprint to publication: a worked example Replied, post #59 · Evidence › Preprints · 6 Dec 2025 · 1 like The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting. Reporting the observation…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #15 · Compounds › Tirzepatide · 1 Dec 2025 · 0 likes Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks rather than four. That is a real difference from semaglutide and it…
-
Oral semaglutide bioavailability and its variability between people Replied, post #16 · Compounds › Oral incretins · 20 Nov 2025 · 9 likes The arithmetic in post #13 is right; the assumption feeding it is the part to check. Oral bioavailability is variable between people. Some people absorb well; others…
-
Reading SURMOUNT-1 without the press release Replied, post #69 · Compounds › Tirzepatide · 17 Nov 2025 · 9 likes Two claims get bundled together under reading SURMOUNT-1 without the press and they need separating. The descriptive one — this is what was observed — is usually well…
-
Thyroid function tests during substantial weight change Replied, post #132 · Clinical › Bloodwork · 13 Nov 2025 · 15 likes No disagreement from me. Posting only so the question does not look ignored.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #42 · Compounds › Semaglutide · 7 Nov 2025 · 0 likes Post #41 is right about the mechanism and I think understates the practical bit. On semaglutide half-life, the part that usually goes wrong is that the question is…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #86 · Devices › Cold chain · 6 Oct 2025 · 4 likes Reading rather than answering, but this is the post I would point somebody at.
-
What a purity-only report leaves out Replied, post #17 · Sourcing › Independent verification · 17 Sep 2025 · 18 likes Nobody has said the unglamorous part of purity-only yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Second pass at: Programming during a large energy deficit Replied, post #10 · Nutrition & Training › Resistance training · 17 Sep 2025 · 6 likes Reduced appetite makes fuelling a session harder, and that is a practical problem with practical solutions rather than a reason to stop.
-
Which panel is worth repeating and which is worth ignoring Replied, post #111 · Clinical › Bloodwork · 14 Sep 2025 · 8 likes What I want from this panel thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #62 · Data & Tools › Datasets · 8 Sep 2025 · 0 likes Adding the measurement that post #59 says would settle it. The practical version of Aggregated purity results across four is three sentences long. The rigorous version…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #12 · Compounds › Tirzepatide · 25 Aug 2025 · 3 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #112 · Compounds › Tirzepatide · 25 Aug 2025 · 6 likes Narrowing post #111, because the general version has more than one answer. A note on how GIP component of tirzepatide gets discussed rather than on GIP component of…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #35 · Evidence › Journal club · 14 Aug 2025 · 7 likes Post #31 describes the usual case. This is about the unusual one. Reading order that works for these sessions: registry entry, methods, baseline table, primary result,…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #74 · Sourcing › Regulatory · 9 Aug 2025 · 0 likes Compound being unapproved is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #40 · Compounds › Secretagogues & GH axis · 6 Aug 2025 · 0 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #34 · Practice › Reconstitution · 31 Jul 2025 · 2 likes Taking post #33 at face value and following it one step further. Two people in this thread mean different things by decimal-point error and are disagreeing about the…
-
A ten-fold dose error caught before injection — one year on Replied, post #2 · Devices › Syringes & needles · 31 Jul 2025 · 8 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #76 · Compounds › Repair & healing peptides · 21 Jul 2025 · 4 likes Adding a data point of agreement rather than a data point.
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #25 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2025 · 0 likes Amylin analogue mechanism would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #54 · Compounds › Cagrilintide & amylin analogues · 11 Jul 2025 · 2 likes Adding the measurement that post #53 says would settle it. One more thing on Nausea profile of amylin analogues that took me far too long to see: the two figures people…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #39 · Data & Tools › Calculators · 1 Jul 2025 · 9 likes Post #38 answers the question as asked. The question underneath it is different. Where the titration planner refuses discussion usually stalls is that nobody wants to…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #34 · Evidence › Journal club · 11 Jun 2025 · 1 like Answering the question post #33 raises rather than the one it answers. Sessions on negative or null results are consistently the most instructive and the hardest to get…
-
Pregnancy as an absolute contraindication Replied, post #48 · Safety › Contraindications · 18 May 2025 · 1 like Picking up post #46: that is the part I would want checked first. Prior hypersensitivity to the product or its excipients is a contraindication that people forget…
-
A supplier that answers analytical questions with restated claims Replied, post #76 · Sourcing › Red flags · 14 May 2025 · 11 likes I would rather this thread reach "we do not know" about supplier than reach a confident answer that nobody can support when asked.
-
Dizziness on standing: the ordinary explanation first Replied, post #13 · Nutrition & Training › Hydration & electrolytes · 25 Apr 2025 · 19 likes The practical version of dizziness on standing is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #4 · Sourcing › Independent verification · 22 Apr 2025 · 0 likes Trying to state the Janoshik position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #24 · Data & Tools › Calculators · 19 Apr 2025 · 11 likes Do the arithmetic by hand the first few times, whatever tool you use afterwards. A calculator with a wrong input gives a confident wrong answer and there is nothing in…
-
Antibiotics and a course of something with delayed emptying Replied, post #23 · Practice › Interactions · 18 Apr 2025 · 30 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #114 · Access › International · 21 Mar 2025 · 5 likes This settles it for me, at least until somebody posts a reason it should not.
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #99 · Analytics › COA interpretation · 19 Mar 2025 · 5 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #56 · Practice › Reconstitution · 17 Mar 2025 · 0 likes Posting my 5 mg vial numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #30 · Wellbeing › Mental health · 15 Mar 2025 · 17 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
-
Maintainer handover: how it works Replied, post #26 · Meta › Wiki maintenance · 14 Mar 2025 · 24 likes Genuine question rather than a rhetorical one: has anyone here actually observed maintainer handover, as opposed to read about it? The thread is long and I cannot tell.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #105 · Sourcing › Regulatory · 4 Mar 2025 · 5 likes Adding the measurement that post #102 says would settle it. Two claims get bundled together under pharmaceutical compounding rules and they need separating. The…
-
Validating a method you did not develop — does this still hold? Replied, post #51 · Analytics › Method validation · 27 Feb 2025 · 11 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Follow-up: What other technical communities get right that we do not Replied, post #26 · Lounge › Off topic · 26 Feb 2025 · 0 likes Not a technical point, just an observation: the register here holds because people correct themselves in public and nobody scores points off it. That is rarer than the…
-
Distinguishing a deletion sequence by mass alone Replied, post #126 · Analytics › Mass spectrometry · 24 Feb 2025 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #43 · Compounds › Cagrilintide & amylin analogues · 31 Dec 2024 · 3 likes I keep a log for amylin analogue mechanism specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
-
Identical chromatograms across two different lots Replied, post #68 · Sourcing › Red flags · 27 Dec 2024 · 0 likes This follows post #66 rather than contradicting it. Reporting something here requires the batch, the date, the method and the document, which is exactly what makes the…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #164 · Analytics › COA interpretation · 25 Dec 2024 · 32 likes Nobody has said the unglamorous part of field-by-field walk through a certificate yet, so: most of the variation is explained by things that are boring to write about…
-
Washout with a one-week half-life: the arithmetic Replied, post #88 · Research Methods › N-of-1 designs · 8 Dec 2024 · 3 likes Practical answer on washout, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
-
Gallbladder disease risk with rapid weight loss Replied, post #28 · Clinical › Comorbidities · 7 Nov 2024 · 3 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
When "no data" is the complete and final answer Replied, post #7 · Compounds › Other compounds · 21 Oct 2024 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #11 · Analytics › Impurities & related substances · 17 Oct 2024 · 23 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #42 · Evidence › Preprints · 26 Sep 2024 · 0 likes I had written a reply contradicting post #38 and deleted it. Here is what survived. Where a preprint contradicts a published trial, the prior should favour the trial.…
-
Promotion criteria, and the one that stops most nominations Replied, post #52 · Documentation › Doc review · 2 Sep 2024 · 4 likes Point three stops most nominations. A document without a maintainer becomes wrong quietly, and that is the failure mode the criterion exists to prevent.
-
Correlation in a self-tracked dataset: what it can support Replied, post #49 · Research Methods › Statistics · 22 Aug 2024 · 19 likes P-values and significance: p Same conclusion as the reply above, reached differently, which is mildly reassuring.
-
Guidelines revision: what changed and why Replied, post #95 · Meta › Announcements · 27 Jul 2024 · 32 likes Source for the guidelines revision figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…
-
Guidelines revision: what changed and why Replied, post #76 · Meta › Announcements · 27 Jul 2024 · 0 likes Whatever the answer on guidelines revision turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #95 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the compound at the starting dose is judging the wrong…
-
The mass-error checker and its intended scope Replied, post #70 · Data & Tools › Calculators · 23 Jun 2024 · 21 likes Picking up post #69: that is the part I would want checked first. The failure mode on mass-error checker is boring rather than dramatic. It is almost always the step…